Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 1 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-15 Lacey David L. Director Grant or award · Director Stock Option (right to buy) +31,250 31,250
2025-05-19 Lacey David L. Director Grant or award · Director Stock Option (right to buy) +25,000 25,000
2024-05-20 Lacey David L. Director Grant or award · Director Stock Option (right to buy) +25,000 25,000
2023-05-04 Lacey David L. Director Grant or award · Director Stock Option (right to buy) +25,000 25,000
2022-05-05 Lacey David L. Director Grant or award · Director Stock Option (right to buy) +17,500 17,500
2021-05-06 Lacey David L. Director Grant or award · Director Stock Option (right to buy) +17,500 17,500

Page 1 of 1 · 6 trades